Wenrui Lin
Impact in
-
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
- Immunotherapy and Immune Responses
- Dermatology top 10%
- Dermatology and Skin Diseases
Papers in
- Oncology 5
- Cutaneous Melanoma Detection and Management 3
- Cytokine Signaling Pathways and Interactions 1
- COVID-19 and healthcare impacts 1
-
- Melanoma and MAPK Pathways 1
- Co-authors
- Juan Su (6 shared papers)Lixia Lü (1 shared paper)Jia Guo (1 shared paper)Xiang Chen (3 shared papers)H. Zhang (1 shared paper)Ming Gao (2 shared papers)Tianqi Ma (1 shared paper)Minxue Shen (2 shared papers)
In The Last Decade
Wenrui Lin
7 papers receiving 224 citations
Wenrui Lin's Hit Papers
Peers
Comparison fields: 5 of 67
- Immunology 131
- Dermatology 48
- Pharmaceutical Science 16
- Biological Psychiatry 3
- Toxicology 4
Countries citing papers authored by Wenrui Lin
This map shows the geographic impact of Wenrui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenrui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenrui Lin more than expected).
Fields of papers citing papers by Wenrui Lin
This network shows the impact of papers produced by Wenrui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenrui Lin. The network helps show where Wenrui Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenrui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Signaling pathways and targeted therapies for psoriasis Hit paper breakdown → | 2023 | 202 |
| 2 | 2022 | 10 | |
| 3 | 2022 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 |
About Wenrui Lin
Wenrui Lin is a scholar working on Oncology, Molecular Biology, Dermatology, Surgery and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 225 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (3 papers), Dermatological and COVID-19 studies (1 paper), Optical Coherence Tomography Applications (1 paper), Infection Control and Ventilation (1 paper), Cardiac, Anesthesia and Surgical Outcomes (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), COVID-19 and healthcare impacts (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Immunology (131 citations), Dermatology (48 citations), Pharmaceutical Science (16 citations), Biological Psychiatry (3 citations) and Toxicology (4 citations). Wenrui Lin has collaborated with scholars based in China and Canada. Frequent co-authors include Juan Su, Lixia Lü, Jia Guo, Xiang Chen, H. Zhang, Ming Gao, Tianqi Ma, Minxue Shen, Lina Zhang and Zhiwen Ye. Their work appears in journals such as Signal Transduction and Targeted Therapy, International Journal of Environmental Research and Public Health, Journal of Medical Virology, Frontiers in Psychology and Frontiers in Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.